The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)
2 other identifiers
observational
10
1 country
1
Brief Summary
This study is designed to better understand the molecular biology of paroxysmal nocturnal hemoglobinuria (PNH) and to determine if prion protein (PrP) functions in long term hematopoietic stem cell renewal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 23, 2008
CompletedFirst Posted
Study publicly available on registry
July 25, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedAugust 9, 2011
August 1, 2011
4.6 years
July 23, 2008
August 5, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identify the mutation causing the predominant clones through analysis of extracted DNA/RNA from erythroid colonies
After sample is obtained
Secondary Outcomes (2)
Reconfirmation of PrP expression in human granulocytes, hematopoietic progenitors and stem cells
After sample is obtained
Analysis of PrP function in human long term hematopoietic stem cells
After sample is obtained
Study Arms (1)
Affected Population
Subjects suspected of having Paroxysmal Nocturnal Hemoglobinuria (PNH)
Eligibility Criteria
Patients with paroxysmal nocturnal hemoglobinuria (PNH)
You may qualify if:
- Subjects suspected of or diagnosed with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Age \> 7
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- National Institutes of Health (NIH)collaborator
Study Sites (1)
University of Utah
Salt Lake City, Utah, 84132, United States
Related Publications (3)
Durig J, Giese A, Schmucker U, Kretzschmar HA, Duhrsen U. Decreased prion protein expression in human peripheral blood leucocytes from patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2001 Mar;112(3):658-62. doi: 10.1046/j.1365-2141.2001.02602.x.
PMID: 11260069BACKGROUNDRisitano AM, Holada K, Chen G, Simak J, Vostal JG, Young NS, Maciejewski JP. CD34+ cells from paroxysmal nocturnal hemoglobinuria (PNH) patients are deficient in surface expression of cellular prion protein (PrPc). Exp Hematol. 2003 Jan;31(1):65-72. doi: 10.1016/s0301-472x(02)01011-1.
PMID: 12543108BACKGROUNDZhang CC, Steele AD, Lindquist S, Lodish HF. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2184-9. doi: 10.1073/pnas.0510577103. Epub 2006 Feb 7.
PMID: 16467153BACKGROUND
Biospecimen
Whole Blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Josef T Prchal, MD
University of Utah
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 23, 2008
First Posted
July 25, 2008
Study Start
May 1, 2006
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
August 9, 2011
Record last verified: 2011-08